Pacira BioSciences (PCRX) Competitors

Pacira BioSciences (NASDAQ:PCRX) and Perrigo (NYSE:PRGO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk, community ranking and media sentiment.

Do insiders & institutionals have more ownership in PCRX or PRGO?

99.7% of Pacira BioSciences shares are owned by institutional investors. Comparatively, 95.9% of Perrigo shares are owned by institutional investors. 6.4% of Pacira BioSciences shares are owned by insiders. Comparatively, 0.7% of Perrigo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Which has better valuation & earnings, PCRX or PRGO?

Pacira BioSciences has higher earnings, but lower revenue than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Pacira BioSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pacira BioSciences	$702.77M	1.64	$41.96M	-$2.28	-10.91
Perrigo	$4.34B	0.88	-$12.70M	-$1.31	-21.06

Does the media prefer PCRX or PRGO?

In the previous week, Pacira BioSciences had 2 more articles in the media than Perrigo. MarketBeat recorded 10 mentions for Pacira BioSciences and 8 mentions for Perrigo. Pacira BioSciences' average media sentiment score of 1.06 beat Perrigo's score of 0.93 indicating that Pacira BioSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pacira BioSciences	4 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Perrigo	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, PCRX or PRGO?

Pacira BioSciences has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Comparatively, Perrigo has a beta of 0.46, meaning that its share price is 54% less volatile than the S&P 500.

Does the MarketBeat Community favor PCRX or PRGO?

Pacira BioSciences received 60 more outperform votes than Perrigo when rated by MarketBeat users. Likewise, 71.60% of users gave Pacira BioSciences an outperform vote while only 66.38% of users gave Perrigo an outperform vote.

Company	Underperform	Outperform
Pacira BioSciences	Outperform Votes 832 71.60%	Underperform Votes 330 28.40%
Perrigo	Outperform Votes 772 66.38%	Underperform Votes 391 33.62%

Is PCRX or PRGO more profitable?

Perrigo has a net margin of -3.64% compared to Pacira BioSciences' net margin of -13.07%. Pacira BioSciences' return on equity of 13.42% beat Perrigo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pacira BioSciences	-13.07%	13.42%	7.19%
Perrigo	-3.64%	7.38%	3.18%

Do analysts recommend PCRX or PRGO?

Pacira BioSciences presently has a consensus target price of $26.44, indicating a potential upside of 6.33%. Perrigo has a consensus target price of $33.00, indicating a potential upside of 19.59%. Given Perrigo's higher probable upside, analysts plainly believe Perrigo is more favorable than Pacira BioSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pacira BioSciences	1 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.33
Perrigo	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25

Summary

Pacira BioSciences beats Perrigo on 14 of the 18 factors compared between the two stocks.